VINEETLAB36.00

Vineet Laboratories Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMMANGALAMLASAKREBSBIOALPABALPHARMAORTINGLOBENATCAPSUQMcap ₹69.2 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Returns
Return on Common Equity2.96-137.853.52
Return on Assets0.88-21.361.29
Return on Capital Employed11.45-93.2210.55
Return on Invested Capital5.94-33.577.08
Margins
EBITDA Margin4.78-21.7114.27
Operating Margin3.11-25.0510.21
Incremental Operating Margin31.04-159.35
Pretax Margin0.24-27.702.16
Net Income Margin0.68-26.922.70
FCF Margin-7.7413.93-22.63
Additional
Effective Tax Rate-182.642.8113.39
Sustainable Growth Rate2.96-137.853.52
Incremental Operating Margin %31.04-159.35
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.